DR10624 Injection for hypertriglyceridemia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 2 registered trials.

Why this status

  1. 9 Jul 2026: Trial registered, NCT07693777
  2. 30 Sep 2026: Trial registered, NCT07848880

The trials

NCT07693777: A Phase III Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemia

State
Not started
Phase
Phase 3
People
480 planned
Started
17 Aug 2026
Primary completion
14 Feb 2029
Arms
Dose 1 DR10624 Group, Dose 2 DR10624 Group
Results
None posted
  1. 9 Jul 2026: Trial registered

NCT07848880: A Phase 2 Study to Evaluate the Efficacy and Safety of DR10624 in Subjects With Moderate Hypertriglyceridemia and Diabetic Kidney Disease

State
Not started
Phase
Phase 2
People
315 planned
Started
Oct 2026
Primary completion
Apr 2028
Arms
Dose 1 DR10624 Group, Dose 2 DR10624 Group, Dose 3 DR10624 Group
Results
None posted
  1. 30 Sep 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.